IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Performance
Performance Report
Performance Report
Documents
Omaxe IPO is a Book Built listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in New Delhi and caters to Real Estate sector. Citigroup Global Markets India , Jm Financial are the merchant bankers of Omaxe IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th July 2007.
Omaxe IPO posted revenues of ₹ 1439.68 crores and PAT of ₹ 257.26 crores in FY25 on annualised basis.
Revenue:
₹ 1,439.68 Cr.
EBITDA Margin:
24.71
% 
Net Worth: ₹ 461.00 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 3.09 times
Financial results of Omaxe IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY7 | FY6 | FY5 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 2476.22 | 1220.60 | 464.16 | ||
| Net Worth | 461.00 | 201.12 | 79.07 | ||
| Total Debt | 1263.65 | 372.26 | 164.95 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
1439.68 | 819.86 | 396.59 | ||
EBITDA
EBITDA on annualised basis |
355.69 | 152.59 | 29.58 | ||
PAT
PAT on annualised basis |
257.26 | 118.81 | 5.04 | ||
Omaxe IPO PAT Margin is 17.87 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Omaxe IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY7 | FY6 | FY5 |
|---|---|---|---|
| EBITDA Margin (%) | 24.71 | 18.61 | 7.46 |
| PAT Margin (%) | 17.87 | 14.49 | 1.27 |
| EPS (₹) | 16.60 | 7.91 | 0.38 |
| ROE (%) | 55.80 | 59.07 | 6.37 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 10.39 | 9.73 | 1.09 |
| Debt to Equity | 2.74 | 1.85 | 2.09 |
The market Capitalisation of Omaxe IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Omaxe IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Omaxe IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Omaxe IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Omaxe IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Omaxe IPO reported revenue of ₹ 1439.68 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Omaxe IPO provide insights into sales growth, market demand, and business scalability.
Omaxe recorded an EBITDA of ₹ 355.69 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Omaxe Profit After Tax (PAT) is ₹ 257.26 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 1,439.68 Cr.
EBITDA Margin:
24.71
%
Net Worth: ₹ 461.00 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 3.09 times
Omaxe operates in Real Estate and Prominent Real Estate Development And Construction Firm. The Issue is listed on BSE,NSE in Jun, 2025. Omaxe IPO size was with Issue price of .
Merchant Banker(s) of Omaxe IPO: Citigroup Global Markets India Private Limited , Jm Financial Limited
Omaxe IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Omaxe IPO listed at a listing price of against the offer price of .
The current market price of Omaxe is .
Why Us?
